title: [The current approach to the treatment of the patients with metastatic colorectal cancer].
abstract: Colorectal cancer is one of the most common malignant tumors. Despite the constant promotion of prevention remains around 20- 30% of cases dia-gnosed in the metastatic stage and approximately 50- 60% of patients developed the late dissemination. In 80- 90% of them we can find already unresectable metastases. Although surgical treatment is basic modality of therapy, with using mo-dern targeted therapy in combination with chemotherapy we can achieve longterm complete remission in the cases of advanced tumor and we can significantly prolonged the life of patients with this disease now. About 40- 50% patients in advanced stages who underwent metastasectomy survives 5-years and 10year survival rate is up to 25%. When administered systemic treatment median overall survival in these cases reaches around 24 months.
authors.forename: J
authors.initials: J
authors.lastname: Halámková
authors.forename: J
authors.initials: J
authors.lastname: Tomášek
authors.forename: S
authors.initials: S
authors.lastname: Rybníčková
authors.forename: D
authors.initials: D
authors.lastname: Adámková Krákorová
authors.forename: B
authors.initials: B
authors.lastname: Bencsiková
authors.forename: I
authors.initials: I
authors.lastname: Kiss
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000628:therapy*; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents